This study aimed to describe allele, genotype, and phenotype frequencies for CYP2C19 and evaluate the effect of the CYP2C19 variants on treatment with ticagrelor-aspirin vs clopidogrel-aspirin in terms of prognosis for patients with minor stroke and high-risk TIA. This evidence concerns the gene CYP2C19 and transient ischemic attack.